Tumor-LN-oC project has kicked-off!August 18, 2021
On May 7th, 2021 Tumor-LN-oC project (Tumor and Lymph Node on Chip for cancer studies) was officially kicked-offvia online conferencing service where all partners from 11 organizations participated. The project is coordinated by Institute of Communication and Computer Systems from Greece, with the participation of Eindhoven University of Technology (Netherlands), Biomedical Research Foundation Academy Of Athens (Greece), Åbo Akademi (Finland), Alpes Lasers (Switzerland)), Rayfos Ltd (UK), Vienna University of Technology (Austria), Elvesys (France), PhosPrint P.C. (Greece), Asphalion SL (Spain) and Amires (Czech Republic).
Tumor-LN-oC aims to offer a comprehensive solution for a robust, automated tumor-lymph node-on-chip platform that will connect primary surgically removed human tumors and LN tissue from the same cancer patient. This will allow to study the interaction of primary tumors with lymph nodes, identify their chemical signature, and offer personalized treatment relying on molecular characterization of lymph node metastasizing cells.